Search Videos and More

Showing 1 - 9 of 9 results

Dana-Farber’s Dr. Toni Choueiri Elected to the Association of American Physicians News

Dana-Farber’s Dr. Toni Choueiri Elected to the Association of American Physicians

Dana-Farber Cancer Institute’s Dr. Toni Choueiri, Director of the Lank Center for Genitourinary Oncology, was recently elected to one of the nation’s most prestigious medical organizations, The Association of American Physicians (AAP).
Stuart Orkin Awarded Breakthrough Prize in Life Sciences News

Stuart Orkin Awarded Breakthrough Prize in Life Sciences

Stuart H. Orkin, MD, Investigator at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, David G. Nathan Distinguished Professor, Harvard Medical School and Investigator, Howard Hughes Medical Institute, has been honored with The Breakthrough Prize in Life Sciences for discovering how the body turns off fetal hemoglobin after birth, a finding that led to a new treatment strategy for sickle cell disease. Dr. Orkin shares the prize with SweeLay Thein, Investigator at the National Institutes of Health (NIH).
Dana-Farber Researchers Receive AACR 2026 Scientific Achievement Awards News

Dana-Farber Researchers Receive AACR 2026 Scientific Achievement Awards

Dr. Eliezer Van Allen and Dr. Kimberly Stegmaier have been selected by the American Association for Cancer Research (AACR) as recipients of 2026 Scientific Achievement Awards. Both researchers will be honored during the AACR Annual Meeting 2026, held April 17-22 at the San Diego Convention Center.
Dana-Farber Chair of Pathology, Dr. Kathleen Burns, Elected as Fellow of the American Association for the Advancement of Science News

Dana-Farber Chair of Pathology, Dr. Kathleen Burns, Elected as Fellow of the American Association for the Advancement of Science

Dr. Kathleen Burns, Chair of Pathology at Dana-Farber Cancer Institute, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is a distinguished lifetime honor bestowed upon AAAS members by their peers.
More Than 145 Dana-Farber Affiliated Faculty Named as 2026 Top Doctors™ in Boston Magazine News

More Than 145 Dana-Farber Affiliated Faculty Named as 2026 Top Doctors™ in Boston Magazine

Boston magazine has named more than 145 physicians affiliated with Dana-Farber Cancer Institute to its annual "Top Doctors" guide. Drawing from a Castle Connolly Medical Ltd. physician database, the Boston magazine Top Doctors™ list draws from hundreds of Boston-area physicians in many medical specialties
Tracing a Career of Unrelenting Discovery News

Tracing a Career of Unrelenting Discovery

Dr. Ben Ebert's Legacy of Collaborative Research Fuels Innovation at Dana-Farber
Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber News

Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber

Kimberly Stegmaier, MD, was named Chair of Pediatric Oncology at Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital, in an announcement made today. Her appointment is effective April 1, 2025.
Dana-Farber President and CEO Laurie Glimcher, MD, Announces Her Plans to Step Down Capping a Highly Successful Tenure Marked with Discovery and Innovation News

Dana-Farber President and CEO Laurie Glimcher, MD, Announces Her Plans to Step Down Capping a Highly Successful Tenure Marked with Discovery and Innovation

Acclaimed medical oncologist and researcher Benjamin Ebert, MD, PhD, appointed to lead the world-renowned cancer center
William Hahn is a 2023 Award of Excellence Honoree by Hope Funds News

William Hahn is a 2023 Award of Excellence Honoree by Hope Funds

William Hahn, MD, PhD, executive vice president and chief operating officer at Dana-Farber Cancer Institute, is one of three exceptional individuals honored by Hope Funds with its 2023 Award of Excellence in the areas of Basic Science and Medicine.